CEO Martin VanTrieste (Civica Rx)

Non­prof­it Civi­ca goes af­ter in­sulin prices in a big way, prep­ping for $30 vials by 2024

As mil­lions of in­sulin-de­pen­dent Amer­i­cans have seen their out-of-pock­et costs soar over the last few years, the mar­ket con­trolled by the three big in­sulin man­u­fac­tur­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.